Joseph Friedman

27.2k total citations · 6 hit papers
60 papers, 2.1k citations indexed

About

Joseph Friedman is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Emergency Medicine. According to data from OpenAlex, Joseph Friedman has authored 60 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Public Health, Environmental and Occupational Health, 20 papers in Epidemiology and 13 papers in Emergency Medicine. Recurrent topics in Joseph Friedman's work include Opioid Use Disorder Treatment (31 papers), HIV, Drug Use, Sexual Risk (15 papers) and Forensic Toxicology and Drug Analysis (12 papers). Joseph Friedman is often cited by papers focused on Opioid Use Disorder Treatment (31 papers), HIV, Drug Use, Sexual Risk (15 papers) and Forensic Toxicology and Drug Analysis (12 papers). Joseph Friedman collaborates with scholars based in United States, Mexico and Norway. Joseph Friedman's co-authors include Helena Hansen, Chelsea L. Shover, David L. Schriger, Samir Akre, Philippe Bourgois, Leo Beletsky, Fernando Montero, David Goodman‐Meza, Emmanuela Gakidou and Joseph P. Gone and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Joseph Friedman

56 papers receiving 2.0k citations

Hit Papers

Xylazine spreads across the US: A growing component of th... 2021 2026 2022 2024 2022 2022 2022 2023 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis
    2022 224 citations Joseph Friedman, Fernando Montero et al. Drug and Alcohol Dependence profile →
  2. Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic
    2022 196 citations Joseph Friedman, Helena Hansen JAMA Psychiatry profile →
  3. Trends in Drug Overdose Deaths Among US Adolescents, January 2010 to June 2021
    2022 143 citations Joseph Friedman, Morgan Godvin et al. profile →
  4. Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010–2021
    2023 128 citations Joseph Friedman, Chelsea L. Shover profile →
  5. COVID-19 and the Drug Overdose Crisis: Uncovering the Deadliest Months in the United States, January‒July 2020
    2021 119 citations Joseph Friedman et al. profile →
  6. The Overdose Crisis among U.S. Adolescents
    2024 36 citations Joseph Friedman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Friedman United States 24 1.0k 606 353 320 280 60 2.1k
Patricia R. Freeman United States 23 940 0.9× 556 0.9× 294 0.8× 267 0.8× 153 0.5× 106 2.0k
Shannon M. Monnat United States 27 825 0.8× 584 1.0× 323 0.9× 790 2.5× 106 0.4× 78 2.6k
W. David Bradford United States 23 501 0.5× 366 0.6× 388 1.1× 528 1.6× 49 0.2× 77 1.8k
Lainie Rutkow United States 22 912 0.9× 318 0.5× 231 0.7× 389 1.2× 156 0.6× 127 1.9k
Melissa Davey‐Rothwell United States 23 490 0.5× 916 1.5× 130 0.4× 872 2.7× 67 0.2× 75 2.1k
Rachel M. Burns United States 25 691 0.7× 643 1.1× 250 0.7× 568 1.8× 296 1.1× 70 2.5k
Anthony Shakeshaft Australia 30 575 0.6× 1.5k 2.5× 455 1.3× 1.6k 5.0× 129 0.5× 203 3.3k
Marian Shanahan Australia 22 546 0.5× 660 1.1× 294 0.8× 334 1.0× 64 0.2× 93 1.6k
William R. Ponicki United States 33 649 0.6× 1.8k 2.9× 261 0.7× 1.2k 3.6× 143 0.5× 91 3.0k
Allison Diamant United States 32 1.2k 1.2× 431 0.7× 338 1.0× 1.1k 3.4× 77 0.3× 84 3.4k

Countries citing papers authored by Joseph Friedman

Since Specialization
Citations

This map shows the geographic impact of Joseph Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Friedman more than expected).

Fields of papers citing papers by Joseph Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Friedman. The network helps show where Joseph Friedman may publish in the future.

Co-authorship network of co-authors of Joseph Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Friedman. A scholar is included among the top collaborators of Joseph Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Friedman. Joseph Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, David T., Joseph Friedman, Suzanne Tamang, & Joseph P. Gone. (2025). Drug overdose mortality rates among non-Hispanic American Indian/Alaska Native individuals, 1999–2022. Annals of Epidemiology. 105. 80–88.
2.
Friedman, Joseph, et al.. (2025). The Detection of Xylazine in Tijuana, Mexico: Triangulating Drug Checking and Clinical Urine Testing Data. Journal of Addiction Medicine. 20(1). 22–25. 3 indexed citations
3.
Shover, Chelsea L., et al.. (2025). High variation in purity of consumer-level illicit fentanyl samples in Los Angeles, September 2023–April 2025. International Journal of Drug Policy. 145. 104977–104977.
4.
Friedman, Joseph. (2025). Assessing an ICD-10 code approach for estimating xylazine-involved overdose deaths in the United States. Drug and Alcohol Dependence. 274. 112781–112781. 3 indexed citations
5.
Friedman, Joseph, et al.. (2025). Xylazine prevalence and concentration in the Los Angeles fentanyl market, 2023–2025. Drug and Alcohol Dependence Reports. 16. 100364–100364. 1 indexed citations
6.
Calderón-Villarreal, Alhelí, et al.. (2025). Managing xylazine-involved overdoses in a community harm reduction setting: lessons from Tijuana, Mexico. Harm Reduction Journal. 22(1). 2–2. 4 indexed citations
7.
Shover, Chelsea L., et al.. (2024). Leveraging pooled medical examiner records to surveil complex and emerging patterns of polysubstance use in the United States. International Journal of Drug Policy. 141. 104397–104397.
8.
Bórquez, Annick, et al.. (2024). Changes in injecting versus smoking heroin, fentanyl, and methamphetamine among people who inject drugs in San Diego, California, 2020–2023. Drug and Alcohol Dependence. 259. 111318–111318. 14 indexed citations
9.
Friedman, Joseph & Helena Hansen. (2024). Trends in Deaths of Despair by Race and Ethnicity From 1999 to 2022. JAMA Psychiatry. 81(7). 731–731. 9 indexed citations
10.
Friedman, Joseph, Philippe Bourgois, Shoshana V. Aronowitz, et al.. (2023). Rethinking urban-rural designations in public health surveillance of the overdose crisis and crafting an agenda for future monitoring. International Journal of Drug Policy. 118. 104072–104072. 1 indexed citations
11.
Sud, Abhimanyu, Kellia Chiu, Joseph Friedman, & Julie Dupouy. (2023). Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States. International Journal of Drug Policy. 120. 104161–104161. 4 indexed citations
12.
Friedman, Joseph, Morgan Godvin, Annick Bórquez, et al.. (2023). Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study. Drug and Alcohol Dependence. 249. 110819–110819. 26 indexed citations
13.
Friedman, Joseph, Helena Hansen, & Joseph P. Gone. (2023). Deaths of despair and Indigenous data genocide. The Lancet. 401(10379). 874–876. 28 indexed citations
14.
Seamans, Marissa J., et al.. (2023). Drug overdose mortality rates by educational attainment and sex for adults aged 25–64 in the United States before and during the COVID-19 pandemic, 2015–2021. Drug and Alcohol Dependence. 255. 111014–111014. 5 indexed citations
15.
Montero, Fernando, Philippe Bourgois, & Joseph Friedman. (2022). Potency-Enhancing Synthetics in the Drug Overdose Epidemic: Xylazine (“Tranq”), Fentanyl, Methamphetamine, and the Displacement of Heroin in Philadelphia and Tijuana. SHILAP Revista de lepidopterología. 4(2). 204–222. 27 indexed citations
16.
Friedman, Joseph, Mirza Balaj, Nazrul Islam, et al.. (2022). Inequalities in COVID-19 mortality: defining a global research agenda. Bulletin of the World Health Organization. 100(10). 648–650. 2 indexed citations
17.
Friedman, Joseph, Patrick Liu, Christopher Troeger, et al.. (2021). Predictive performance of international COVID-19 mortality forecasting models. Nature Communications. 12(1). 2609–2609. 68 indexed citations
18.
Friedman, Joseph, Alhelí Calderón-Villarreal, Kristian Heggebø, et al.. (2021). COVID-19 and the Nordic Paradox: a call to measure the inequality reducing benefits of welfare systems in the wake of the pandemic. Social Science & Medicine. 289. 114455–114455. 5 indexed citations
19.
Friedman, Joseph, George Karandinos, Laurie Kain Hart, et al.. (2019). Structural vulnerability to narcotics-driven firearm violence: An ethnographic and epidemiological study of Philadelphia’s Puerto Rican inner-city. PLoS ONE. 14(11). e0225376–e0225376. 25 indexed citations
20.
Friedman, Joseph, Katrina Gwinn, Jennifer DeWolfe, et al.. (2002). A family with a tau P301L mutation presenting with parkinsonism. Parkinsonism & Related Disorders. 9(2). 121–123. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia R. Freeman Breakdown of academic impact, for papers by Shannon M. Monnat Breakdown of academic impact, for papers by W. David Bradford Breakdown of academic impact, for papers by Lainie Rutkow Breakdown of academic impact, for papers by Melissa Davey‐Rothwell Breakdown of academic impact, for papers by Rachel M. Burns Breakdown of academic impact, for papers by Anthony Shakeshaft Breakdown of academic impact, for papers by Marian Shanahan Breakdown of academic impact, for papers by William R. Ponicki Breakdown of academic impact, for papers by Allison Diamant
Rankless by CCL
2026